AdvisorShares Trust 13D and 13G filings for InMed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-02 4:13 pm Sale |
2025-03-31 | 13G | InMed Pharmaceuticals Inc. INM |
AdvisorShares Trust | 0 0.000% |
-1,833 (Position Closed) |
Filing |
| 2024-11-12 1:44 pm Purchase |
2024-09-30 | 13G | InMed Pharmaceuticals Inc. INM |
AdvisorShares Trust | 1,833 8.770% |
1,833 (New Position) |
Filing |